Formation of Carbonyl Chloride in Carbon Tetrachloride Metabolism by Rat Liver in Vitro

Cancer Research

Volumn 39, Issue 10, 1979, Pages 3942-3947

  Shah, Harshida ^a   Hartman, Sally P ^a   Weinhouse, Sidney ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; GLUTATHIONE; LIVER ENZYME; PHOSGENE;

AEROBIC METABOLISM; DRUG METABOLISM; LIVER; LIVER CANCER; RAT; THEORETICAL STUDY;

AEROBIOSIS; ANIMAL; CARBON TETRACHLORIDE; CARBOXYLIC ACIDS; FORMATES; GLUTATHIONE; IN VITRO; LIVER; MALE; MODELS, CHEMICAL; PHOSGENE; RATS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0018695638     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Anders, M. W., Stevens, J. L., Sprague, R. W., Shaath, Z., and Ahmed, A. E. Metabolism of haloforms to carbon monoxide. II. In vivo studies. Drug Metab. Dispos., 6: 556–560, 1978.
2. Butler, T. C. The reduction of carbon tetrachloride in vivo and reduction of carbon tetrachloride to chloroform in vitro by tissues and tissue constituents. J. Pharmacol. Exp. Ther., 134: 311–319, 1961.
3. Cessi, C., Colombini, C., and Mameli, L. The reaction of liver proteins with a metabolite of carbon tetrachloride. Biochem. J., 101: 46c, 1966.
4. Fishbein, H. Industrial mutagens and potential mutagens. I. Halogenated aliphatic derivatives. Mutat. Res., 32: 267–308, 1976.
5. Fowler, S. J. L. Carbon tetrachloride metabolism in the rabbit. Br. J. Pharmacol., 37: 733–737, 1969.
6. Gillette, J. R., Mitchell, J. R., and Brodie, B. B. Biochemical mechanisms of drug toxicity. Annu. Rev. Pharmacol., 14: 271–288, 1974.
7. Glende, E. A., Jr., Hruszkewycz, A. M., and Reeknagel, R. O. Critical role of lipid peroxidation in carbon tetrachloride-induced loss of aminopyridine demethylase, cytochrome P-450 and glucose 6-phosphatase. Biochem. Pharmacol., 25: 2163–2170, 1976.
8. I. Gordis, E. Lipid metabolites of carbon tetrachloride. J. Clin. Invest., 48: 203–209, 1969.
9. International Agency for Research on Cancer. The evaluation of carcinogenic risk of chemicals to man. IARC Monogr., 1: 53–60, 1971.
10. Jacoby, W. B., Habig, W. H., Ketley, J. H., and Pabst, M. J. Glutathione S-transferases: catalytic aspects. In: I. M. Arias and W. B. Jacoby (eds.), Glutathione, pp. 189–212. New York: Raven Press, 1976.
11. Johnson, M. K. Studies on glutathione S-alkyl transferase of the rat. Biochem. J., 98: 44–56, 1965.
12. Kaneko, T., Shimokobe, T., Ota, Y., Toyokawa, E., Inui, T., and Shiba, T. Syntheses and properties of 2-oxothiazolidine-4 carboxylic acid and its derivatives. Bull. Chem. Soc. Jpn., 37: 242–244, 1964.
13. Kubic, V. L., and Anders, M. W. Metabolism of dihalomethanes to carbon monoxide. II. In vitro studies. Drug Metab. Dispos., 3: 104–111, 1975.
14. Kubic, V. L., Anders, M. W., Engel, R. R., Barlow, C. H., and Caughey, W. S. Metabolism of dihalomethanes to carbon monoxide. I. In vivo studies. Drug Metab. Dispos., 2: 53–57, 1974.
15. Mansuy, D., Beaune, P., Cresteil, T., Lange, M., and Leroux, J. P. Evidence for phosgene formation during liver microsomal oxidation of chloroform. Biochem. Biophys. Res. Commun., 79: 513–517, 1977.
16. McCann, J., Choi, E., Yamasaki, E., and Ames, B. N. Detection of carcinogens as mutagens in the SalmonellNmicrosome test: assay of 300 chemicals. Proc. Natl. Acad. Sci. U.S.A., 72: 5135–5139, 1975.
17. Mukai, F. H., and Goldstein, B. D. Mutagenicity of malonaldehyde, a decomposition product of peroxidized polyunsaturated fatty acids. Science, 191: 868–869, 1976.
18. Paul, G. G., and Rubinstein, D. Metabolism of carbon tetrachloride and chloroform by the rat. J. Pharmacol. Exp. Ther., 141: 141–148, 1963.
19. Pawlowsky, R., and Frosolono, M. F. Effect of phosgene on rat lungs after single high exposure. Arch. Environ. Health, 32: 278–283, 1977.
20. Pohl, L. R., Bhooshan, B., Whitaker, N. F., and Krishna, G. Phosgene: a metabolite of chloroform. Biochem. Biophys. Res. Commun., 79: 684–691, 1977.
21. Poyer, J. L., Floyd, R. A., McCay, P. B., Janzen, E. G., and Davis, E. R. Spin-trapping of the trichloromethyl radical produced during enzymic NADPH oxidation in the presence of carbon tetrachloride or bromotrichloromethane. Biochim. Biophys. Acta, 539: 402–409, 1978.
22. Ratney, R. S., Wegman, D. H., and Elkins, H. B., In vivo conversion of methylene chloride to carbon monoxide. Arch. Environ. Health, 28: 223–226, 1974.
23. Recknagel, R. O., and Glende, E. A., Jr. Carbon tetrachloride hepatoxicity: an example of lethal cleavage. CRC Crit. Rev. Toxicol., 2: 263–297, 1973.
24. Reynolds, E. S. Liver parenchymal cell injury. IV. Pattern of incorporation of carbon and chlorine from carbon tetrachloride into chemical constituents of liver in vivo. J. Phannacol. Exp. Ther., 155: 117–126, 1967.
25. Rodkey, F. L., and Collison, H. A. Effect of dihalogenated methanes on the in vivo production of carbon monoxide and methane by rats. Toxicol. Appl. Pharmacol., 40: 39–47, 1977.
26. Rubinstein, D., and Kanics, L. The conversion of carbon tetrachloride and chloroform to carbon dioxide by rat liver homogenates. Can. J. Biochem., 42: 1577–1585, 1964.
27. Shamberger, R. J., Andreone, T. L., and Willis, C. E. Antioxidants and cancer. IV. Initiating activity of malonaldehyde as a carcinogen. J. Natl. Cancer Inst., 53: 1771–1773, 1974.
28. Sipes, I. G., Krishana, G., and Gillette, J. R. Bioactivation of carbon tetrachloride, chloroform and bromotrichloromethane: role of cytochrome P-450. Life Sci., 20: 1541–1548, 1977.
29. Uehleke, H., Hellmer, K. H., and Tarabelli, S. Binding of 14C-carbon tetrachloride to microsomal proteins in vitro and formation of CHCl3 by reduced liver microsomes. Xenobiotica, 3: 1–11, 1973.
30. Uehleke. H., and Werner, T. A comparative study on the irreversible binding of labeled halothane trichlorofluoromethane chloroform, and carbon tetrachloride to hepatic protein and lipids in vitro and in vivo. Arch. Toxicol., 34: 289–308, 1975.
31. Uehleke, H., Werner, T., Greim, H., and Kramer, M. Metabolic activation of haloalkanes and tests in vitro for mutagenicity. Xenobiotica, 7; 393–400, 1977.
32. Villarruel, M. C., and Castro, J. A. Irreversible binding of carbon tetrachloride to microsomal phospholipids. Free radical nature of the reactive specie and alterations in the physico-chemical properties of the target fatty acids. Res. Commun. Chem. Pathol. Pharmacol., 10: 105–115, 1975.
33. Villarruel, M. C., Diaz-Gomez, M. I., and Castro, J. A. The nature of the irreversible binding of carbon tetrachloride to microsomal lipids. Toxicol. Appl. Pharmacol., 33: 106–114, 1975.
34. Weinhouse, S., and Friedmann, B. Study of precursors of formate in the Intact rat. J. Biol. Chem., 197: 733–740, 1953.
35. Wolf, C. R., Mansuy, D., Nastainczyk, W., Deutschmann, G., and Ullrich, V. The reduction of polyhalogenated methanes by liver microsomal cytochrome P-450. Mol. Pharmacol., 13: 698–705, 1977.